Venoruton® Improves the quality of life of the patients with Venous Insufficiency

The measures posturales are the main recommendation to treat the Chronic Venous Illness

12 of August of 2022
Venoruton STADA

The fourth edition of the study STADA Health Report, made to a representative sample of 30.000 people in 15 countries of Europe, has revealed that 73% of the Spaniards suffers some annoyance in the legs related with the Chronic Venous Illness. In concrete, the 15,7 % signals to suffer tired legs, the 26 % has feeling of heaviness, the 18 % itching and the 13,2 % recognises that they appear him varices during the period estival. Regarding gender, the women signal significantly a greater frequency of these annoyances, mainly in those groups of age comprised between the 35-44 and 45-54 years.

Venoruton Is a medicine whose active principle basesin the oxerutinas, composed of natural origin with properties vasoprotectoras that relieve the symptoms of the slight Venous Insufficiency reinforcing and protecting the walls of the veins, reducing the swell and the pain of legs and facilitating the microcirculación and the oxygenation to local level. Venoruton Has showed to improve the quality of life of the patients with Venous Insufficiency in a 46,8 % in comparison with the diosmina and the hesperidina that showed an improvement of the 15,5 %1,2.

The range of products complementswith Venorutox, a complement alimentary with extracts of Rusco and Spark, vitamin C and And, and magnesium, that contributes to keep the normal venous circulation and relieves the feeling of heavy legs.

Tags